Pay in 4 interest-free payments of $6.77 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
Tirzepatide showed greater reductions in HbA1c and body weight at week 52, along with a lower risk of hypoglycemia [67]
It is also a reasonable starting point for patients new to GLP-1 therapy who want to assess tolerability before considering dual-action compounds
Time spent at elevated temperatures accelerates degradation
1 This expansion is driven by more than just obesity
US$ 27.39
US$ 28.83
US$ 22.10
US$ 23.66
US$ 26.76
US$ 20.72
US$ 21.16
